1. Periganglionic inflammation elicits a distally radiating pain hypersensitivity by promoting COX-2 induction in the dorsal root ganglion.
- Author
-
Amaya F, Samad TA, Barrett L, Broom DC, and Woolf CJ
- Subjects
- Analysis of Variance, Animals, Autonomic Fibers, Preganglionic pathology, Behavior, Animal drug effects, Biophysics, Cyclooxygenase 2 genetics, Cytokines pharmacology, Disease Models, Animal, Enzyme Inhibitors pharmacology, Freund's Adjuvant adverse effects, Ganglia, Spinal drug effects, Gene Expression drug effects, Gene Expression physiology, In Vitro Techniques, Lactones pharmacology, Male, Pain Measurement, RNA, Messenger metabolism, Rats, Rats, Sprague-Dawley, Reaction Time drug effects, Sciatica complications, Sulfones pharmacology, Cyclooxygenase 2 metabolism, Ganglia, Spinal metabolism, Hyperalgesia etiology, Inflammation complications, Pain Threshold physiology
- Abstract
We have developed a model in which inflammation contiguous to and within a dorsal root ganglion (DRG) was generated by local application of complete Freund's adjuvant (CFA) to the L4 lumbar spinal nerve as it exits from the intervertebral foramen. The periganglionic inflammation (PGI) elicited a marked reduction in withdrawal threshold to mechanical stimuli and an increase in heat pain sensitivity in the ipsilateral hindpaw in the absence of any hindpaw inflammation. The pain sensitivity appeared within hours and lasted for a week. The PGI also induced a prominent increase in IL-1beta and TNF-alpha levels in the DRG and of cyclooxygenase-2 (COX-2) expression in neurons and satellite cells. A selective COX-2 inhibitor reduced the PGI-induced hyperalgesia. We also show that IL-1beta induces COX-2 expression and prostaglandin release in DRG neurons in vitro in a MAP kinase-dependent fashion. The COX-2 induction was prevented by ERK and p38 inhibitors. We conclude that periganglionic inflammation increases cytokine levels, including IL-1beta, leading to the transcription of COX-2 and prostaglandin production in the affected DRG, and thereby to the development of a dermatomally distributed pain hypersensitivity.
- Published
- 2009
- Full Text
- View/download PDF